# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-049986
Filing Date
2024-04-22
Accepted
2024-04-22 16:08:54
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | tm242793d3_defa14a.htm | DEFA14A | 15569
2 | GRAPHIC | tm242793d3_defa14aimg001.jpg | GRAPHIC | 408663
3 | GRAPHIC | tm242793d3_defa14aimg002.jpg | GRAPHIC | 217964
| Complete submission text file | 0001104659-24-049986.txt |  | 880002

Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37467 | Film No.: 24861277
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)